A detailed history of Gordian Capital Singapore Pte LTD transactions in Adagene Inc. stock. As of the latest transaction made, Gordian Capital Singapore Pte LTD holds 48,342 shares of ADAG stock, worth $89,916. This represents 0.14% of its overall portfolio holdings.

Number of Shares
48,342
Previous 24,000 101.43%
Holding current value
$89,916
Previous $46,000 108.7%
% of portfolio
0.14%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$1.65 - $2.97 $40,164 - $72,295
24,342 Added 101.43%
48,342 $96,000
Q2 2025

Aug 14, 2025

BUY
$1.39 - $2.09 $7,088 - $10,659
5,100 Added 26.98%
24,000 $46,000
Q1 2025

May 15, 2025

BUY
$1.52 - $2.1 $28,728 - $39,690
18,900 New
18,900 $28,000

Others Institutions Holding ADAG

About Adagene Inc.


  • Ticker ADAG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,423,200
  • Market Cap $80.8M
  • Description
  • Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...
More about ADAG
Track This Portfolio

Track Gordian Capital Singapore Pte LTD Portfolio

Follow Gordian Capital Singapore Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gordian Capital Singapore Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gordian Capital Singapore Pte LTD with notifications on news.